GlassScriptPhysician profile
Neil Sharma
NPI 1013477884
$1,301.33
in general payments reported to CMS, 2019-2025
11 companies · $905 in 2025
The $905 reported for 2025 was more than what 84% of Diagnostic Radiology providers received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $397 · 2025: $905.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,301.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,301.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Terumo Medical Corporation | $378.23 | 2024-2025 | Azur Cx Detachable, Glidewire, Hydropearl |
| Stryker Corporation | $308.28 | 2025 | Flowtriever, Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Shockwave Medical, INC | $185.94 | 2025 | |
| Trisalus Life Sciences, INC. | $110.63 | 2024-2025 | Trinav Infusion System |
| Boston Scientific Corporation | $107.19 | 2024-2025 | Embold Fibered |
| Medtronic, INC. | $68.95 | 2024 | Gi Genius |
| Inari Medical, INC. | $45.52 | 2024-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Bard Peripheral Vascular, INC. | $34.73 | 2025 | Trek, Covera |
| Thrombolex, INC. | $28.22 | 2025 | Bashir Endovascular Catheter |
| Cordis US Corp. | $17.03 | 2025 | Mynx Control Venous |
| Teleflex LLC | $16.61 | 2024 | Arrow |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Neil Sharma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.